"10.1371_journal.pone.0085248","plos one","2014-01-07T00:00:00Z","Carmen Mart√≠nez; Ana M Ortiz; Yasmina Juarranz; Amalia Lamana; Iria V Seoane; Javier Leceta; Rosario Garc√≠a-Vicu√±a; Rosa P Gomariz; Isidoro Gonz√°lez-√Ålvaro","Departamento de Biolog√≠a Celular, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain; Servicio de Reumatolog√≠a, Hospital Universitario de la Princesa, Instituto de Investigaci√≥n Sanitaria la Princesa, Madrid, Spain; Departamento de Biolog√≠a Celular, Facultad de Biolog√≠a, Universidad Complutense de Madrid, Madrid, Spain","Conceived and designed the experiments: CM AMO RPG IG-A. Performed the experiments: CM YJ AL IVS IG-A AMO JL. Analyzed the data: IG-A CM RPG AMO. Wrote the paper: CM IG-A RPG RG-V.","A patent application (P201230827) for the use of VIP as a marker of prognostic in autoimmune diseases has been deposited by the Fundaci√≥n de Investigaci√≥n Biom√©dica del Hospital Universitario de la Princesa at the Oficina Espa√±ola de Patentes y Marcas. The full name of the patent application is: VIP use as a prognostic marker of autoimmune diseases. This does not alter the authors‚Äô adherence to all the PLOS ONE policies.","2014","01","Carmen Mart√≠nez","CM√",9,TRUE,4,7,4,4,TRUE,TRUE,TRUE,2,"7;9",TRUE
